Genflow Biosciences (LON:GENF) (OTCQB:GENFF)’s Post

What It Is: Gene therapy involves introducing, removing, or altering genetic material within a person's cells to treat or prevent disease. It aims to address the root cause of genetic disorders by correcting defective genes. Types of Gene Therapy: Somatic Gene Therapy: Targets non-reproductive cells, affecting only the individual receiving the therapy. Germline Gene Therapy: Targets reproductive cells (sperm or eggs), which could be passed on to future generations. This approach is more controversial and currently not widely practiced.) 🌐 www.drdomenicopratico.com | www.thepraticolab.com 📚 https://lnkd.in/ePYMYRWn 🧠 https://lnkd.in/eJjn_Shz 🐦 https://lnkd.in/e-NvsgBK 🖋️ https://lnkd.in/ecVzXE8D #genetherapy #geneticdisorders #MedicalInnovation #somaticgenetherapy #germlinegenetherapy #GeneticResearch #Biotechnology #FutureOfMedicine #precisionmedicine #geneticengineering #praticolab #AlzheimersResearch #alzheimerscare #alzheimersawareness #domenicopratico

What It Is: Gene therapy involves introducing, removing, or altering genetic material within a person's cells to treat or prevent disease. It aims to address the root cause of genetic disorders by correcting defective genes. Types of Gene Therapy: Somatic Gene Therapy: Targets non-reproductive cells, affecting only the individual receiving the therapy. Germline Gene Therapy: Targets reproductive cells (sperm or eggs), which could be passed on to future generations. This approach is more controversial and currently not widely practiced.) 🌐 www.drdomenicopratico.com | www.thepraticolab.com 📚 https://lnkd.in/ePYMYRWn 🧠 https://lnkd.in/eJjn_Shz 🐦 https://lnkd.in/e-NvsgBK 🖋️ https://lnkd.in/ecVzXE8D #genetherapy #geneticdisorders #MedicalInnovation #somaticgenetherapy #germlinegenetherapy #GeneticResearch #Biotechnology #FutureOfMedicine #precisionmedicine #geneticengineering #praticolab #AlzheimersResearch #alzheimerscare #alzheimersawareness #domenicopratico

New Blog Post! Potency Assays for Cell and Gene Therapy: Statistical Challenges Read here: https://buff.ly/3WFDqk4 Discover the unique challenges and potential solutions in potency assays for cell and gene therapy in our latest blog post. We delve into the complexities of cell and gene therapy including the difficulties in conducting bioassays due to limited lot size, lack of reference materials, complex mechanism of action, and inherent variability in manufacturing. High variability in potency assays can lead to issues in batch release testing and require strategies to minimize it such as efficient replication strategy and chosing an appropriate dose-response model. #bioassay #biostatistics #drugdevelopment #cellTherapy #geneTherapy #challenges #solutions

📢 Unlocking Gene Therapy's Potential with ssDNA 🧬 The article discusses the emerging role of single-stranded DNA ssDNA in gene therapy. 🧬 ssDNA holds promise in democratizing cell and gene therapies as well as gene-based technologies. 🧬 New approaches utilizing ssDNA can improve the efficiency and accessibility of gene therapy treatments. 🧬 These advancements have the potential to revolutionize the field of gene therapy and make it more widely available. #BioprocessUpdates #GeneTherapy #ssDNA #EmergingRole #CellTherapy #GeneBasedTechnologies #Advancements #Efficiency #Accessibility #RevolutionizeGeneTherapy #WidelyAvailable #DemocratizingTherapies #PromisingTechnology #GeneticAdvancements #DNAInnovation #BiomedicalResearch ▷ Read the full article here: 📎 https://lnkd.in/dmVTVnS8

Forbes just released the latest insightful article on the current progression in Regenerative Medicine, specifically focusing on gene therapy. As a professional in the field, I am amazed by the potential of gene therapy in eliminating the root cause of diseases by manipulating genes. The article, part of a series on Regenerative Medicine, delves into the past, present, and future of gene therapy and its role in transforming healthcare. It's truly a golden era in medical history, with breakthroughs in the 2000s and 2010s leading to new treatments for previously incurable genetic disorders. At PeopleSolutions Healthcare Staffing Inc. we are excited to see the possibilities and hope that gene therapy brings for millions of people around the world. Check out the article. Source: https://lnkd.in/e6u8dNt4 #genetherapy #regenerativemedicine #healthcare #medicalbreakthrough #PeopleSolutionsHealthCare #Forbes

🧬 Dive into our latest solution brief to uncover how TetraScience is revolutionizing ddPCR workflows, addressing data challenges, and unlocking new possibilities. 🚀 Key Features: ✅ Optimize ddPCR workflows for enhanced efficiency ✨ AI-native data capabilities for deeper insights 🔍 Collect, search, and analyze results faster #GeneTherapy #ddPCR #DataOptimization #TetraScience #InnovationInScience #BiotechRevolution

🚀 Elevating Biopharma Innovation with TetraScience 🧬 Modern medicine, exemplified by gene therapies, is reshaping healthcare for the better. Yet, in the pursuit of new drug candidates, scientists and labs face daily challenges. While brilliant minds and cutting-edge tech drive excitement, efficient data management is the linchpin for continuous innovation. By placing scientific data at the forefront, we accelerate the journey from discovery to market. Join us at TetraScience in revolutionizing biopharma research. Droplet digital PCR (ddPCR) is quickly becoming a mainstay of gene therapy. But scientists are struggling with data handling. Discover how the Tetra Scientific Data and AI Cloud™ streamlines ddPCR workflows, improving scientific outcomes in gene therapy. https://lnkd.in/gfaNPv3j #TetraScience #genetherapy #ddPCR #ScientificDataAndAICloud #ScientificOutcomes #cloudcomputing #lifesciences

Find out how droplet digital PCR (ddPCR) is transforming gene therapy—and the data challenges holding it back. Our solution brief shows how TetraScience optimizes ddPCR workflows. Collect, search, and analyze results faster. Plus, unlock deeper insights with AI-native data. Learn more: https://lnkd.in/gCuPn2pT #TetraScience #genetherapy #ddPCR #ScientificDataAndAICloud #ScientificOutcomes

𝑾𝒐𝒓𝒍𝒅’𝒔 𝒇𝒊𝒓𝒔𝒕 𝒈𝒆𝒏𝒆 𝒕𝒉𝒆𝒓𝒂𝒑𝒚 𝒇𝒐𝒓 𝒂 𝒓𝒂𝒓𝒆 𝒓𝒆𝒕𝒊𝒏𝒂𝒍 𝒅𝒊𝒔𝒆𝒂𝒔𝒆 Fantastic news from the world of gene therapy! AAVantgarde Bio is embarking on an exciting phase 1/2 clinical trial to treat retinitis pigmentosa associated with Usher syndrome type 1B. The groundbreaking procedure, carried out in Naples (Italy), was made possible by an innovative gene therapy platform developed by TIGEM in Pozzuoli, which enables the transfer of large genes. This cutting-edge technique, called “dual-AAV,” uses two AAV-like vectors, each carrying half of the genetic blueprint needed to create the therapeutic protein. Once inside the cell, these halves combine, allowing the protein to be produced in the right amounts, opening up thrilling possibilities for treatment! 👉 https://lnkd.in/dum9qQdA #GeneTherapy #RetinitisPigmentosa #UsherSyndrome #AAVantgardeBio #TIGEM #DualAAV   #MedicalInnovation #RareDiseaseResearch 

Discover how the Tetra Scientific Data and AI Cloud™ streamlines ddPCR workflows, improving scientific outcomes in gene therapy. https://lnkd.in/e2AT3HRu #genetherapy #ddPCR #ScientificDataAndAICloud #ScientificOutcomes